KMTS
Kestra Medical Technologies, Ltd. NASDAQ Listed Mar 6, 2025$19.93
+4.45%
vs $19.08
Mkt Cap $987.2M
52w Low $14.46
40.4% of range
52w High $28.01
50d MA $20.73
200d MA $23.28
P/E (TTM)
-3.9x
EV/EBITDA
—
P/B
4.8x
Debt/Equity
0.2x
ROE
-80.1%
P/FCF
-9.8x
RSI (14)
43.40
ATR (14)
$1.38
Beta
1.09
50d MA
$20.73
200d MA
$23.28
Avg Volume
286.3K
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The company's Cardiac Recovery System platform also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.
CIK (SEC)
Phone
425 279 8002
3933 Lake Washington Blvd NE · Kirkland, WA 98033 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | AMC | -0.60 | -0.61 | -1.7% | 21.14 | +0.0% | -7.4% | -0.1% | -2.4% | +2.6% | +5.7% | — |
| Dec 11, 2025 | AMC | -0.59 | -0.62 | -4.4% | 24.91 | +6.2% | +5.1% | +1.2% | +2.0% | -0.7% | +1.2% | — |
| Sep 11, 2025 | AMC | -0.66 | -0.46 | +30.3% | 18.40 | +8.7% | +18.6% | +3.9% | +2.3% | +2.3% | +6.2% | — |
| Jul 17, 2025 | AMC | — | -1.05 | — | 16.46 | +2.1% | -3.4% | +4.6% | +2.4% | -1.8% | +1.5% | — |
| Apr 30, 2024 | AMC | — | -0.45 | — | — | — | — | — | — | — | — | — |
| Jan 31, 2024 | AMC | — | -0.44 | — | — | — | — | — | — | — | — | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 9 | Goldman Sachs | Maintains | Neutral → Neutral | — | $19.62 | $19.31 | -1.6% | -1.9% | -7.2% | +5.0% | +5.2% | +2.3% |
| Apr 7 | BTIG | Maintains | Buy → Buy | — | $19.32 | $19.18 | -0.7% | +0.9% | +0.7% | -1.9% | -7.2% | +5.0% |
| Mar 25 | BTIG | Maintains | Buy → Buy | — | $20.70 | $20.75 | +0.2% | -0.6% | -4.4% | -1.1% | -5.8% | +8.7% |
| Mar 18 | BTIG | Maintains | Buy → Buy | — | $21.14 | $21.14 | +0.0% | -7.4% | -0.1% | -2.4% | +2.6% | +5.7% |
| Dec 15 | Goldman Sachs | Maintains | Neutral → Neutral | — | $26.17 | $26.15 | -0.1% | +1.2% | +2.0% | -0.7% | +1.2% | +0.6% |
| Dec 12 | Piper Sandler | Maintains | Overweight → Overweight | — | $24.91 | $26.45 | +6.2% | +5.1% | +1.2% | +2.0% | -0.7% | +1.2% |
| Dec 12 | Wells Fargo | Maintains | Overweight → Overweight | — | $24.91 | $26.45 | +6.2% | +5.1% | +1.2% | +2.0% | -0.7% | +1.2% |
| Jul 17 | Wells Fargo | Maintains | Overweight → Overweight | — | $15.35 | $15.30 | -0.3% | +7.2% | -3.4% | +4.6% | +2.4% | -1.8% |
| Apr 16 | Goldman Sachs | Maintains | Neutral → Neutral | — | $24.13 | $24.08 | -0.2% | +1.9% | -0.3% | -3.9% | +2.0% | +1.4% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Webster Brian Daniel | See Remarks | Sell | 15,000 | $20.81 | $312K | 395,467 | +4.45% | — |
| May 15, 2026 | Webster Brian Daniel | See Remarks | Sell | 6,845 | $21.46 | $147K | 334,786 | +1.07% | +0.83% |
| May 15, 2026 | Webster Brian Daniel | See Remarks | Sell | 8,155 | $20.53 | $167K | 341,631 | +1.07% | +0.83% |
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Fmr Llc | 5,721,054 | $114M | Reduced | Mar 2026 |
| 2 | Andera Partners | 2,695,192 | $54M | Added | Mar 2026 |
| 3 | Yu Fan | 2,282,519 | $45M | New | Mar 2026 |
| 4 | Franklin Resources Inc | 1,243,205 | $25M | Added | Mar 2026 |
| 5 | Vanguard Capital Management Llc | 1,212,693 | $24M | New | Mar 2026 |
| 6 | Hood River Capital Management Llc | 655,877 | $13M | Added | Mar 2026 |
| 7 | Next Century Growth Investors Llc | 457,558 | $9M | Reduced | Mar 2026 |
| 8 | Ubs Group Ag | 349,687 | $7M | Added | Mar 2026 |
| 9 | Jennison Associates Llc | 219,355 | $6M | Added | Dec 2025 |
| 10 | Sei Investments Co | 237,116 | $5M | Added | Mar 2026 |
| 11 | Morgan Stanley | 170,904 | $5M | Added | Dec 2025 |
| 12 | Vanguard Portfolio Management Llc | 218,827 | $4M | New | Mar 2026 |
| 13 | Millennium Management | 197,491 | $4M | Reduced | Mar 2026 |
| 14 | Northern Trust Corp | 191,609 | $4M | Added | Mar 2026 |
| 15 | Seven Grand Managers, Llc | 100,000 | $3M | New | Dec 2025 |
| 16 | Bellevue Group Ag | 115,590 | $2M | — | Mar 2026 |
| 17 | Bank Of New York Mellon Corp | 70,113 | $1M | Added | Mar 2026 |
| 18 | Bank Of America Corp /de/ | 51,479 | $1M | Added | Mar 2026 |
| 19 | Sigma Planning Corp | 25,250 | $670K | — | Dec 2025 |
| 20 | Tudor Investment Corp | 31,900 | $636K | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$987.2M
Enterprise Value
$790.7M
P/E (TTM)
-3.89x
Forward P/E
—
PEG Ratio
-0.07x
P/B
4.81x
P/S
16.50x
P/FCF
-9.76x
EV/EBITDA
—
Shares Out
49.5M
Financials (TTM)
Revenue
$59.8M
Net Income
-$113.8M
EBITDA
-$98.0M
Free Cash Flow
-$101.2M
Op Cash Flow
-$77.6M
EPS Basic
$-5.13
EPS Diluted
$-5.13
EPS Forward
$-2.19
Gross Margin
40.5%
Op Margin
-177.8%
Net Margin
-190.3%
Balance Sheet
Total Assets
$295.7M
Total Liab.
$90.3M
Total Equity
$205.4M
Cash
$237.6M
LT Debt
$41.1M
Book Value/Sh
$4.15
Debt/Equity
0.22x
Current Ratio
6.72
Quick Ratio
6.55
Returns & Growth
ROE
-80.1%
ROA
-53.3%
ROIC
-41.2%
Rev Growth YoY
+115.1%
EPS Growth YoY
-151.5%
Price Returns
2W
-3.7%
1M
+2.6%
3M
-8.7%
6M
-21.2%
12M
-5.6%
Technicals
52W High
$28.01
52W Low
$14.46
50d MA
$20.73
200d MA
$23.28
RSI (14)
43.40
ATR (14)
$1.38
Beta
1.09
Avg Volume
286K
Dividends
Div Rate
$0.03
Div Yield
0.1%
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$28.00
High
$30.00
Low
$24.00
Median
$29.00
Data updated apr 25, 2026 5:42pm
· Source: financialmodelingprep.com